Pediococcus acidilactici CECT9879 (pA1c) counteracts the effect of a high-glucose exposure in c. elegans by affecting the insulin signaling pathway (IIS)

The increasing prevalence of metabolic syndrome-related diseases, including type-2 diabetes and obesity, makes it urgent to develop new alternative therapies, such as probiotics. In this study, we have used Caenorhabditis elegans under a high-glucose condition as a model to examine the potential pro...

Descripción completa

Detalles Bibliográficos
Autores: Yavorov-Dayliev, D. (Deyan)|||/items/35f99656-3058-4d65-88bd-d42c6e50df98, Milagro-Yoldi, F.I. (Fermín Ignacio)|||/items/07cf7af6-1f5f-4720-8c14-5197a7a724eb, Ayo, J. (Josune)|||/items/a7001b37-cdcc-436a-b894-14ef479e92c5, Oneca, M. (María)|||/items/e65ba0f4-287c-4bcc-8933-723d0f1679a1, Aranaz-Oroz, P. (Paula)|||/items/8f6060d1-d2d4-425b-ac46-ffe00907395a
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Universidad de Navarra
Repositorio:Dadun. Depósito Académico Digital de la Universidad de Navarra
Idioma:inglés
OAI Identifier:oai:dadun.unav.edu:10171/116690
Acceso en línea:https://hdl.handle.net/10171/116690
Access Level:acceso abierto
Palabra clave:Caenorhabditis elegans
Daf-16
Diabetes
Insulin-signaling-pathway
Obesity
Probiotic
β-oxidation.
id ES_3939ca7e9e2e44b5f63f6ce61c4e3f08
oai_identifier_str oai:dadun.unav.edu:10171/116690
network_acronym_str ES
network_name_str España
repository_id_str
spelling Pediococcus acidilactici CECT9879 (pA1c) counteracts the effect of a high-glucose exposure in c. elegans by affecting the insulin signaling pathway (IIS)Yavorov-Dayliev, D. (Deyan)|||/items/35f99656-3058-4d65-88bd-d42c6e50df98Milagro-Yoldi, F.I. (Fermín Ignacio)|||/items/07cf7af6-1f5f-4720-8c14-5197a7a724ebAyo, J. (Josune)|||/items/a7001b37-cdcc-436a-b894-14ef479e92c5Oneca, M. (María)|||/items/e65ba0f4-287c-4bcc-8933-723d0f1679a1Aranaz-Oroz, P. (Paula)|||/items/8f6060d1-d2d4-425b-ac46-ffe00907395aCaenorhabditis elegansDaf-16DiabetesInsulin-signaling-pathwayObesityProbioticβ-oxidation.The increasing prevalence of metabolic syndrome-related diseases, including type-2 diabetes and obesity, makes it urgent to develop new alternative therapies, such as probiotics. In this study, we have used Caenorhabditis elegans under a high-glucose condition as a model to examine the potential probiotic activities of Pediococcusacidilactici CECT9879 (pA1c). The supplementation with pA1c reduced C. elegans fat accumulation in a nematode growth medium (NGM) and in a high-glucose (10 mM) NGM medium. Moreover, treatment with pA1c counteracted the effect of the high glucose by reducing reactive oxygen species by 20%, retarding the aging process and extending the nematode median survival (>2 days in comparison with untreated control worms). Gene expression analyses demonstrated that the probiotic metabolic syndrome-alleviating activities were mediated by modulation of the insulin/IGF-1 signaling pathway (IIS) through the reversion of the glucose-nuclear-localization of daf-16 and the overexpression of ins-6 and daf-16 mediators, increased expression of fatty acid (FA) peroxisomal β-oxidation genes, and downregulation of FA biosynthesis key genes. Taken together, our data suggest that pA1c could be considered a potential probiotic strain for the prevention of the metabolic syndrome-related disturbances and highlight the use of C. elegans as an appropriate in vivo model for the study of the mechanisms underlying these diseases.MDPIDadun. Depósito Académico Digital Universidad de Navarra20222022-01-0120222022-01-01journal articlehttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10171/116690reponame:Dadun. Depósito Académico Digital de la Universidad de Navarrainstname:Universidad de NavarraInglésengopen accesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessoai:dadun.unav.edu:10171/1166902026-06-21T12:47:57Z
dc.title.none.fl_str_mv Pediococcus acidilactici CECT9879 (pA1c) counteracts the effect of a high-glucose exposure in c. elegans by affecting the insulin signaling pathway (IIS)
title Pediococcus acidilactici CECT9879 (pA1c) counteracts the effect of a high-glucose exposure in c. elegans by affecting the insulin signaling pathway (IIS)
spellingShingle Pediococcus acidilactici CECT9879 (pA1c) counteracts the effect of a high-glucose exposure in c. elegans by affecting the insulin signaling pathway (IIS)
Yavorov-Dayliev, D. (Deyan)|||/items/35f99656-3058-4d65-88bd-d42c6e50df98
Caenorhabditis elegans
Daf-16
Diabetes
Insulin-signaling-pathway
Obesity
Probiotic
β-oxidation.
title_short Pediococcus acidilactici CECT9879 (pA1c) counteracts the effect of a high-glucose exposure in c. elegans by affecting the insulin signaling pathway (IIS)
title_full Pediococcus acidilactici CECT9879 (pA1c) counteracts the effect of a high-glucose exposure in c. elegans by affecting the insulin signaling pathway (IIS)
title_fullStr Pediococcus acidilactici CECT9879 (pA1c) counteracts the effect of a high-glucose exposure in c. elegans by affecting the insulin signaling pathway (IIS)
title_full_unstemmed Pediococcus acidilactici CECT9879 (pA1c) counteracts the effect of a high-glucose exposure in c. elegans by affecting the insulin signaling pathway (IIS)
title_sort Pediococcus acidilactici CECT9879 (pA1c) counteracts the effect of a high-glucose exposure in c. elegans by affecting the insulin signaling pathway (IIS)
dc.creator.none.fl_str_mv Yavorov-Dayliev, D. (Deyan)|||/items/35f99656-3058-4d65-88bd-d42c6e50df98
Milagro-Yoldi, F.I. (Fermín Ignacio)|||/items/07cf7af6-1f5f-4720-8c14-5197a7a724eb
Ayo, J. (Josune)|||/items/a7001b37-cdcc-436a-b894-14ef479e92c5
Oneca, M. (María)|||/items/e65ba0f4-287c-4bcc-8933-723d0f1679a1
Aranaz-Oroz, P. (Paula)|||/items/8f6060d1-d2d4-425b-ac46-ffe00907395a
author Yavorov-Dayliev, D. (Deyan)|||/items/35f99656-3058-4d65-88bd-d42c6e50df98
author_facet Yavorov-Dayliev, D. (Deyan)|||/items/35f99656-3058-4d65-88bd-d42c6e50df98
Milagro-Yoldi, F.I. (Fermín Ignacio)|||/items/07cf7af6-1f5f-4720-8c14-5197a7a724eb
Ayo, J. (Josune)|||/items/a7001b37-cdcc-436a-b894-14ef479e92c5
Oneca, M. (María)|||/items/e65ba0f4-287c-4bcc-8933-723d0f1679a1
Aranaz-Oroz, P. (Paula)|||/items/8f6060d1-d2d4-425b-ac46-ffe00907395a
author_role author
author2 Milagro-Yoldi, F.I. (Fermín Ignacio)|||/items/07cf7af6-1f5f-4720-8c14-5197a7a724eb
Ayo, J. (Josune)|||/items/a7001b37-cdcc-436a-b894-14ef479e92c5
Oneca, M. (María)|||/items/e65ba0f4-287c-4bcc-8933-723d0f1679a1
Aranaz-Oroz, P. (Paula)|||/items/8f6060d1-d2d4-425b-ac46-ffe00907395a
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Dadun. Depósito Académico Digital Universidad de Navarra
dc.subject.none.fl_str_mv Caenorhabditis elegans
Daf-16
Diabetes
Insulin-signaling-pathway
Obesity
Probiotic
β-oxidation.
topic Caenorhabditis elegans
Daf-16
Diabetes
Insulin-signaling-pathway
Obesity
Probiotic
β-oxidation.
description The increasing prevalence of metabolic syndrome-related diseases, including type-2 diabetes and obesity, makes it urgent to develop new alternative therapies, such as probiotics. In this study, we have used Caenorhabditis elegans under a high-glucose condition as a model to examine the potential probiotic activities of Pediococcusacidilactici CECT9879 (pA1c). The supplementation with pA1c reduced C. elegans fat accumulation in a nematode growth medium (NGM) and in a high-glucose (10 mM) NGM medium. Moreover, treatment with pA1c counteracted the effect of the high glucose by reducing reactive oxygen species by 20%, retarding the aging process and extending the nematode median survival (>2 days in comparison with untreated control worms). Gene expression analyses demonstrated that the probiotic metabolic syndrome-alleviating activities were mediated by modulation of the insulin/IGF-1 signaling pathway (IIS) through the reversion of the glucose-nuclear-localization of daf-16 and the overexpression of ins-6 and daf-16 mediators, increased expression of fatty acid (FA) peroxisomal β-oxidation genes, and downregulation of FA biosynthesis key genes. Taken together, our data suggest that pA1c could be considered a potential probiotic strain for the prevention of the metabolic syndrome-related disturbances and highlight the use of C. elegans as an appropriate in vivo model for the study of the mechanisms underlying these diseases.
publishDate 2022
dc.date.none.fl_str_mv 2022
2022-01-01
2022
2022-01-01
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/10171/116690
url https://hdl.handle.net/10171/116690
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Dadun. Depósito Académico Digital de la Universidad de Navarra
instname:Universidad de Navarra
instname_str Universidad de Navarra
reponame_str Dadun. Depósito Académico Digital de la Universidad de Navarra
collection Dadun. Depósito Académico Digital de la Universidad de Navarra
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869406151301398528
score 15,811543